We have previously identifed a U.V.-response element (URE; TGACAACA) and its bound proteins, members of the AP1 and ATF transcription factor families, in melanoma cells. Using a mutant form of cylic AMP response element binding (CREB), we found that CREBassociated-URE-bound proteins conferred characteristic melanoma phenotypes, including radiation resistance (Oncogene 12 : 2223(Oncogene 12 : , 1996. In the present study we sought to determine which of the CREB-associated proteins confers radiation resistance on human melanoma cells. To this end we puri®ed and identi®ed via microsequencing ATF2 as a major URE-bound and CREB-associated protein in MeWo cells ± a late stage human melanoma cell line. To determine the contribution of ATF2 to radiation resistance, MeWo cells were transfected with ATF2 cDNA lacking the trans-activation domain (ATF2 D1 ± 195 ).
We have previously identifed a U.V.-response element (URE; TGACAACA) and its bound proteins, members of the AP1 and ATF transcription factor families, in melanoma cells. Using a mutant form of cylic AMP response element binding (CREB), we found that CREBassociated-URE-bound proteins conferred characteristic melanoma phenotypes, including radiation resistance (Oncogene 12 : 2223 (Oncogene 12 : , 1996 . In the present study we sought to determine which of the CREB-associated proteins confers radiation resistance on human melanoma cells. To this end we puri®ed and identi®ed via microsequencing ATF2 as a major URE-bound and CREB-associated protein in MeWo cells ± a late stage human melanoma cell line. To determine the contribution of ATF2 to radiation resistance, MeWo cells were transfected with ATF2 cDNA lacking the trans-activation domain (ATF2 D1 ± 195 ). MeWo cells that stably express ATF2 D1 ± 195 showed weaker transcriptional activities and an altered pattern of homo/ hetero dimers. ATF2 D1-195 clones exhibited up to tenfold lower resistance to irradiation by either U.V. or X-rays. The degree of resistance to radiation in the ATF2 D1 ± 195 expressing clones could be increased upon transient transfection with ATF2 wt , but not with phosphorylationdefective mutant ATF2 69, 71 Introduction The increase in melanoma incidence in the past decade is greater than that observed for all other tumor types combined (Grin-Jorgensen, et al., 1992; WHO report, 1994) . Its great propensity to metastasize and its radiation resistance pose major obstacles in melanoma treatment and point to the need to identify mechanisms which underlie these phenotypes.
Transformation of melanocytes into melanoma cells is a multi-step process that can be de®ned by several cellular phenotypic traits. The switch from melanocyte to nevi, to radial growth, and then to a vertical growth phase of autonomous melanoma is associated with decreased dependence on growth factors, diminished anchorage dependence, reduction of contact inhibition, and increased radiation and drug resistance (Herlyn and Houghton, 1992; Lu and Kerbel, 1994) .
As an approach to identifying changes in regulatory proteins that contribute to melanoma development and modulate key phenotypes of this tumor, we have elucidated the cellular response to U.V.-irradiation, a key etiological factor in the development of melanoma (Kraemer et al., 1994) . We characterized a U.V.-responsive element (URE; TGACAACA; Ronai and Weinstein 1990) as well as its bound proteins, AP1 and ATF family members (Rutberg et al., 1994) and kinases, speci®cally jun-NH 2 -terminal kinases (JNK; Adler et al., 1995a,b) . As an AP1-like and CRE-related target sequence, the URE was found within the promoter sequences of stress-responsive genes, including c-jun (Stein et al., 1992) , DNA polymerase B (Narayan et al., 1995) , and cyclin A, (Yoshizumi et al., 1995) , as well as on regulatory regions of viruses that respond to U.V.-irradiation (Rutberg et al., 1991) .
Major dierences in transcriptional activities of UREbound proteins were found after U.V.-irradiation of keratinocytes (Yang et al., 1993a) , melanocytes and melanoma cells (Yang et al., 1993b) , and also in repairde®cient cells of patients with Xeroderma pigmentosum, or Cockayne syndrome (Yang and Ronai, 1995) , some of which could be attributed to a switch in URE-related protein kinases (JNK; Dhar et al., 1996) . To determine the contribution of URE-bound proteins to selective melanoma phenotypes, we utilized a CREB dominant negative construct (KCREB; Yang et al., 1996) which has been mutated within the DNA-binding domain, and thus acts as a potent inhibitor of DNA binding of CREB-associated proteins. Human melanoma cells that constitutively express KCREB exhibit reduced resistance to U.V.-or X-ray radiation (Yang et al., 1996) as well as a marked decrease in tumorigenic and metastatic potential (Xie et al., 1997) . To investigate which of the CREB-associated proteins is directly involved in modifying speci®c characteristics of melanoma phenotypes, we puri®ed URE-bound proteins from melanoma cells.
In the present study we demonstrate that ATF2 is the primary binding protein and regulator of URE-mediated transcription. To explore the possible contribution of ATF2 to characteristic melanoma phenotypes, human melanoma cells were transfected with a mammalian expression vector carrying ATF2 D1±195 which lacks transactivation abilities (Liu and Green, 1990) , and clones that constitutively express ATF2 D1 ± 195 were characterized. We show that ATF2 speci®cally contributes to radiation resistance of human melanoma cells, and discuss possible mechanisms that could confer these changes.
Results

Identi®cation of ATF2 as URE-binding proteins in human melanoma cells
Nuclear protein extracts prepared from the human melanoma cell line MeWo were passed through a non speci®c DNA column, and then through a UREanity column (Rutberg and Ronai 1992) . Speci®c URE-bound material was eluted and analysed via silver-stained SDS ± PAGE, revealing one major band with a MW of 49 kDa and two minor ones with MW of 42 and 40 kDa, respectively (Figure 1a ). Electroblotting to a PVDF membrane, followed by hybridization with 32 P-labeled URE (i.e., Southwestern blot) identi®ed the 49 kDa protein as the primary UREbinding protein that acquires its binding capacities after u.v.-irradiation (Figure 1b) . Microsequencing of this 49 kDa band revealed a 12 aa sequence (SEESRPQSLQ) which shares 100% homology with the aa sequence of ATF2. To con®rm that the aa sequence does indeed correspond to ATF2, an RT ± PCR reaction was performed in which the 5' primer was a degenerate sequence that corresponds to the aa sequence obtained in the microsequencing reaction, whereas the 3' primer corresponds to the DNA-binding domain, which is shared between various members of the ATF and AP1 transcription factor families. The ampli®ed product was a 219 bp fragment which matched the expected size of the ATF2 amplicon. Sequencing this ampli®ed fragment revealed full homology with ATF2 (not shown). Western blots with MeWo proteins using antibodies to ATF2 con®rmed the expression of a 49 kDa protein ( Figure  1c) , which may represent a spliced form of ATF2 (Chatton et al., 1994) , as the full length ATF2 protein exhibits a MW of 68 kDa. Rat ®broblast cells also express the 49 kDa protein (Figure 1c) . The results of the Southwestern blot (Figure 1b ) indicated that homodimers of this spliced form of ATF2 can bind its target sequence (Liu and Green, 1990; Kerppola and Curran, 1993) .
Generating cells that express ATF2 D1 ± 195 Late stage melanoma cells, MeWo, that are highly metastatic and radiation resistant (Yang and Ronai, 1996) were co-transfected with ATF2 construct, which lacks the transactivation domain (ATF2 D1 ± 195 ) and encodes a fusion protein with the ®rst 147aa of GAL4 and pBK-RSV-Neo. Stable transfectants able to grow in medium supplemented with G418 were selected. As a control, MeWo clones that were transfected with an empty mammalian expression vector, were isolated as well. The presence of GAL4 sequences as part of this fusion protein allowed us to use GAL4 and ATF2-based primers to amplify genomic DNA fragments corresponding to the transfected GAL4-ATF2 gene ( Figure 2a) . As a control, a parallel reaction was performed using a 5' primer corresponding to the ATF2, enabling amplification of endogenous ATF2 sequences (Figure 2b ). To con®rm expression of ATF2 D1 ± 195 , RT ± PCR was carried out with primers that recognize the fusion transcript GAL4-ATF2 D1 ± 195 (using 5' primer for GAL4 and 3' primer for ATF2). Two clones (196-4 and 196-9) containing the truncated ATF2 at the genomic level were also found to express the fusion protein ( Figure   - 2 ) were separated on SDS ± PAGE, blotted onto nylon membrane followed by hybridization with 32 P-labeled URE sequence. Bound material was identi®ed via autoradiography. (c) Expression of ATF2 in melanoma and ®broblast cells. Nuclear proteins (50 mg) from MeWo (lane 2) and rat 6 (lane 3) cells were separated on 7% SDS ± PAGE, which was electroblotted to nitrocellulose membrane and incubated with antibodies to ATF2, detected via the use of alkaline phosphatase-conjugated secondary antibodies. First lane contain MW markers with respective sizes shown on the left panel 2c and its corresponding control in Panel D). To quantify the GAL4-ATF D1 ± 195 transcripts, cDNA from the 196-4 clone was subjected to 20 cycle PCR ampli®cation using labeled primers in parallel to the ampli®cation of serially diluted GAL4-ATF2 D1 ± 195 plasmid, which was used as a reference to establish a calibration curve. As shown in Figure 2e , 1 ml of 196-4 cDNA which represents 10 5 cells contains about 8 rg of GAL4-ATF2 D1 ± 195 , corresponding to 1000 transcripts.
To demonstrate expression of the ATF2 D1 ± 195 immunoprecipitation of cellular proteins was carried out using antibodies to GAL4, which is a part of the fusion protein GAL4-ATF2 D1 ± 195 . Immunoprecipitated material was then analysed via immunoblot with antibodies to ATF2. Using this approach we identi®ed sequences using 5' primer for GAL4 and 3' primer for ATF2 D1 ± 195 . Original plasmid DNA was used as positive control (P). The size of ampli®ed fragment is shown on right panel, and MW markers are indicated on left panel. (b) PCR ampli®cation of endogenous ATF2 from genomic DNA. PCR reaction was performed using 5' primer corresponding to N-terminal region of ATF2, allowing ampli®cation of endogenous ATF2 sequences, as a control for the reaction shown in a. Position of the expected 219 bp is shown on right panel. Establishing melanoma cells that stably express ATF2 D1 ± 195 . (c) Ampli®cation of GAL4 ± ATF2 D1 ± 195 sequences from cDNA. The PCR reaction was performed as detailed in panel a with the exception that the template used was cDNA prepared from the indicated cells. Products of ampli®cation seen as 591 bp fragments represent portion of the GAL4 ± ATF2 D1 ± 195 fusion protein transcript. (d) Ampli®cation of endogenous ATF2 sequences from cDNA. The PCR reaction was performed as detailed in panel b with exception of using cDNA was as the template for PCR reaction. The 219 bp fragment ampli®ed represents a portion of ATF2 transcripts. (e) Quantifying the amount of GAL4 ± ATF2 D1 ± 195 expressed. Serially diluted (1/1; 1/10; 1/50; 1/250; 1/500 -lanes 1 ± 6, respectively) GAL4 ± ATF2 D1 ± 195 plasmid and 1 ml of cDNA from 196 ± 4 cells were ampli®ed for 20 cycles with GAL4 and ATF2 primers followed by autoradiography analysis on PAGE. Numbers represent the amount of DNA molecules found in each of the reactions. Given the number of cells used to prepare the template cDNA, the volume of reaction and the size of ATF2 cDNA, 8 rg of material found in the 196 ± 4 cells correspond to about 1000 transcripts. (f) Expression of GAL4 ± ATF2 D1 ± 195 protein in 196 ± 4 and 196 ± 9 clones. Antibodies to GAL4(UBI) were added to 1 mg of proteins prepared from 196 ± 4, 196 ± 9 or MeWo neo cells. Immunoprecipitated material was captured on protein A/G beads and subsequently analysed on immunoblot using antibodies to ATF2. Arrows point to the position of GAL4 ± ATF2 (Figure 3a) . U.V.-irradiation led to a decrease in the level of UREmediated transcriptional activities in MeWo neo cells. The basal transcription in the 196-4 and 196-9 clones remained low after U.V.-irradiation which is attributed to a U.V.-inducible transcriptional inhibitor which we have previously identi®ed (Yang et al., 1993b) . The ability of ATF2 D1 ± 195 to suppress transcriptional activities is in agreement with previous studies performed in COS cells (Liu and Green, 1990) .
Modi®cation of URE-dependent gene expression can be due to changes in the amount of ATF2 homodimers or the type of ATF2 heterodimers with other bZIP family members. To explore such possible changes nuclear proteins from MeWo neo , 196-4, and 196-9 cells were ®rst immunoprecipitated (IP) with antibodies to the N-terminal region of ATF2. Since the transfected form lacks the amino terminal region, the IP material represents endogenous ATF2. To identify possible changes in ATF2-associated proteins the immunoprecipitated material was subjected to immunoblot with antibodies c-jun or CREB which are among the key ATF2-associated proteins. C-jun was found as an ATF2-associated protein in both parent and ATF2 D1 ± 195 cells, suggesting that expression of ATF2 D1 ± 195 did not aect c-jun expression nor did it out-compete c-jun available for heterodimerizing with ATF2 (Figure 3b-I) . Conversely, CREB was no longer found as an ATF2-associated protein in both ATF2 D1 ± 195 clones (Figure 3b-II) . Lack of CREB-ATF2 complexes could be attributed to either quenching of CREB by ATF2 D1 ± 195 or to change in CREB transcription as one of the transcriptional changes mediated by ATF2 D1 ± 195 . Since there are multiple isoforms of ATF2 which exhibit dierent degrees of transcriptional activity we have also analysed the pattern of ATF2 expression in 196-9 and 196-4 clones. As shown in Figure 3b -III the two ATF2 D1 ± 195 clones express the full length 68 kDa ATF2, which was seen in the parent MeWo (Figure (Figure 3b-III) . In addition, a 41 kDa representing constitutively active spliced form of ATF2 was found in both parent and ATF2 D1 ± 195 expressing clones. The newly expressed full length form of ATF2 found in 196-4 and 196-9 ± ATF2 D1 ± 195 expressing cells is likely to be due to a greater stability of the 68 kDa protein. All forms of ATF2 studied here ± truncated (lacking the amino terminal region ATF2 D1 ± 195 ); alternate spliced (49 kDa and 41 kDa); and full length (68 kDa) are capable of binding their target sequences as homodimers or heterodimers although they do exhibit dierent degrees of transcriptional activities (Liu and Green, 1990; Kerppola and Curran 1993; van Dam et al., 1995; Hoeer et al., 1991; Abdel Ha®z Abdel Malek et al., 1993) . The use of GAL4-ATF2 fusion protein does not aect the activities that would be otherwise mediated by ATF2 that lacks the GAL4 portion (Liu and Green, 1990; Kerppola and Curran 1993; van Dam et al., 1995; Hoeer et al., 1991) . Furthermore, the GAL4 portion did not alter either ATF2 N-terminal-dependent transcriptional activity (Liu and Green 1990) or the full length ATF2 intramolecular inhibition (Li and Green, 1996) .
Growth rate of ATF2
D1 ± 195 clones
Both ATF2 D1 ± 195 clones exhibited faster growth rate than the control MeWo neo cells (Figure 4) . The 196-4 cells grew twice as fast as the 196-9 clones and four times faster than MeWo neo cells. Dierences between the two ATF2 D1 ± 195 clones may evolve from dierent expression levels of the ATF2 construct (Figure 2f ) or re¯ect dierent integration sites which may have aected neighboring genes. When assayed for tumorigenicity and metastatic potential, ATF2 D1 ± 195 clones were found to be as potent as their parent cells both in vitro (i.e., soft agar and matrigel) and in vivo upon their sub-cutaneous or tail vein injection into nude mice (not shown).
MeWo AFT2
D1 ± 195 clones are less resistant to radiation A noticeable decrease in resistance to both U.V.-and X-rays was seen in MeWo clones that express ATF2 D1 ± 195 , as compared with MeWo neo cells. Whereas a dose of 4 J/m 2 did not reveal major dierences in resistance of these clones to U.V. To further elucidate the role of ATF2 in radiation resistance, 196-4 cells which express ATF2 D1 ± 195 were transiently transfected with wt or mutant (in which the phosphoacceptor sites for JNK phosphorylation at aa 69 and 71 (Gupta et al., 1995) were replaced) forms of ATF2. Both constructs encode the full length ATF2 molecule, which lacks the GAL4 fusion protein. The thrust of this design is that the transient expression of the respective transcription factor is to confer changes in radiation resistance because expression of ATF2 dependent-genes is modi®ed at the time of irradiation. While ATF2 wt enchanced radiation resistance to the level seen with the parent MeWo cells, the phosphorylation mutant form of ATF2 was not able to mediate such change (Figure 6a ).
Eect of ATF2 on radiation resistance of early stage melanoma
As an alternate approach to determine the role of ATF2 in melanoma resistance to radiation was to express ATF2 in cells of early stage melanoma, which, when compared with the late stage melanoma, exhibit lower radiation resistance (Krasilnikov et al., submitted) . To this end, we transfected ATF2 wt or phosphorylation mutant forms to WM3211 cells which were derived from an early stage melanoma. Cells were subjected to U.V.-irradiation 24 h after transfection, and CFE measurements was performed after another 10 days. While transient expression of the phosphorylation mutant form of ATF2 led to a 10 ± 20% reduction in radiation resistance, the wt form of ATF2 led to a twofold increase in resistance of the WM3211 cells to 32 J/m 2 of U.V.-irradiation ( Figure  6b) . Transfection of the nucleotide excision repair gene ERCC6 into WM3211 cells increased radiation resistance similarly to the increase obtained by transfection of the ATF2 wt construct (Figure 6b ).
ATF2 modulate melanoma cells' resistance to drugs
The eect of ATF2 on drug resistance was studied by maintaining MeWo neo , 196 ± 4 and 196 ± 9 cells in the presence of 5 ± 100 mM of cis-platinum, 0.01 ± 0.05 mM 1-b-D-arabinoufanosylcytosine (araC) or 0.01 ± 0.05 mM of mitomycin C (MMC) for 48 h, followed by change of medium; CFE were analysed after 10 additional Figure 4 Growth rate of MeWo and ATF2 D1 ± 195 cells. Cells were plated to yield equal number after 24 h based on plating eciency. Triplicate cultures were counted at 24 h intervals as indicated in Figure   ATF2 confers radiation resistance to melanoma Z Ronai et al days. Both the 196 ± 4 and 196 ± 9 clones exhibited lower resistance to all three drugs tested, as the degree of survival was 50 ± 80% of the parent MeWo neo cells (Figure 7 ).
Discussion
While radiation resistance poses one of the most serious clinical obstacles to melanoma treatment, its nature is not yet understood. As an approach to the elucidation of mechanisms that confer such radiation resistance we have abrogated transcriptional activities of URE-bound proteins. Initially, we utilized a dominant negative CREB cDNA which carries a point mutation within the DNA-binding domain and by outcompeting CREB-associated proteins, inhibits DNA binding. This approach has yielded melanoma cells that exhibit a marked decrease in resistance to radiation (Yang et al., 1996) . However, because of the nature of the dominant negative CREB construct used, the contributing factor(s) to this switch remain within the category of CREB-associated proteins. The latter include ATF2 and c-jun as primary associates (Hai and Curran 1991; Hai et al., 1989; Abdel-Malek AbdelHa®z et al., 1993) .
The present study provides direct evidence for the role of ATF2 in conferring radiation resistance on human melanoma cells. This conclusion is supported by three independent experiments. First, radiation resistant melanoma cells expressing ATF2 that lack its transactivation domain exhibit about tenfold lower resistance to irradiation by U.V. or X-rays. Second, we have demonstrated the ability to increase the degree of resistance to radiation in the 196-4 and 196-9 clones via the expression of wild type but not phosphorylation defective mutant forms of ATF2 (full length non-GAL4 fusion protein). That ATF2 mutated on aa 69 and 71 could not increase radiation resistance points to the importance of N-terminal phosphorylation in maintaining radiation resistance. Third independent support for the role of ATF2 in conferring radiation resistance comes from the study of early stage melanoma cells, in which expression of ATF2 wt increased radiation resistance (from 50% to 80% survival to a dose of 32 J/m 2 administered to cells that were transiently transfected). The phosphorylation mutant form of ATF2 caused a modest decrease in radiation resistance of both WM3211-and ATF2 D1 ± 195 -expressing clones, suggesting that the transcriptional modi®cations already mediated by ATF2 D1 ± 195 expression could be further enhanced by another mutant form of ATF2. That the transient transfections for measurement of radiation resistance did not result in the same degree seen in the stable clones is attributed to limited transfection eciency (i.e. at the time of irradiation only a fraction of the cells expressed the transiently transfected construct). The eect of ATF2 on resistance was not limited to radiation, as ATF2 expressing clones also demonstrated decreased drug resistance when tested with MMC, AraC or cisplatinum. Since damaged DNA is a common target for physical and chemical treatments tested in the present study, it is possible that the ability of ATF2 to alter resistance is mediated via eliciting changes at the level of DNA repair. This hypothesis is supported by the ®nding that the nucleotide excision repair gene ERCC6 increased radiation resistance of early stage melanoma cells to the degree seen with ATF2 wt . A possible relationship between ATF2 and ERCC6 was implicated on the basis of the ®nding that patients with Cockayne Syndrome group B who are highly sensitive to U.V.-irradiation, exhibit impaired U.V.-activation of JNK, which phosphorylates ATF2 (Dhar et al., 1996) . ATF2 has been implicated in DNA repair via its eect on DNA polymerase b (Narayan et al., 1995) . In addition, ATF2 plays a role in regulation of cell cycle distribution via its eect on cyclin A, p34 cdc2 (Yoshizumi et al., 1995) and by association with Rb (Kim et al., 1992) . We were able to identify changes in p53, p21 cip/waf1 and cyclin A expression in the ATF2 D1 ± 195 -expressing clones, yet, the respective alterations in cell cycle or apoptosis could not be identi®ed (data not shown), possibly because MeWo cells carry a mutant form of p53 (Loganzo and Albino 1994) .
The ATF2 D1 ± 195 construct used in the present studies yielded poor transcriptional activities. This could be attributed, in part, to abrogating CREB association with endogenous ATF2. Under normal conditions, CREB can interact with the bZIP domain of ATF2 to relieve intrinsic suppression of ATF2 transcriptional activities (Hai et al., 1989; Li and Green 1996) . While U.V.-irradiation also confers increased URE binding ability on ATF2, probably via disruption of intramolecular interactions and formation of homodimers, clones expressing the ATF2 D1 ± 195 have yielded dierent ATF2 isoforms, as seen in the appearance of the 68 kDa full length ATF2. Various spliced forms of ATF2 exhibit dierent degrees of transcriptional activities (Maekawa et al., 1991) probably as a result of altered conformation elicited by homo/heterodimerization or phosphorylation. The poor transcriptional activities seen in ATF2 D1 ± 195 -expressing cells could be due to the subset of such ATF2 heterodimers (i.e. 41 : 68; 49 : 68) as well as to changes in other members of the ATF or the AP1 family which are dependent on ATF2 (van Dam et al., 1995) . While we could not detect expression of the 68 kDa full length ATF2 protein in the MeWo cells, it was identi®ed in the clones which express the ATF2 D1 ± 195 cDNA. This ®nding points to possible changes in the stability of ATF2 which occurred in ATF2 D1 ± 195 expressing cells. RT ± PCR revealed similar transcript size and expression level in MeWo, ATF2 neo and ATF2 D1 ± 195 (not shown), further supporting that ATF2 D1 ± 195 expression yielded greater stability of the full length 68 kDa protein.
Unlike the dominant negative CREB-expressing clones, which exhibit impaired metastatic potential (Xie et al., 1997) , ATF2 D1 ± 195 did not alter metastatic capacity indicating that this phenotype could be mediated by other CREB-associated proteins, such as c-jun. Indeed, dominant negative c-jun, which lacks its transactivation domain, was capable of reverting tumorigenicity as well as metastatic potential in mouse epidermal cells (Domann et al., 1994) .
While other cellular pathways are also expected to contribute to the ability of cells to cope with radiation, in a tissue type-dependent manner, the present study demonstrates that ATF2 confers radiation and drug In all cases cells were exposed to the respective drugs for 48 h and plates were stained after 10 days resistance on human melanoma cells. These ®ndings provide the foundation for the hypothesis that melanoma targeted ATF2 modulators may be useful sensitizers in the treatment of tumors of this type.
Materials and methods
Cell lines
Human melanoma (MeWo) cells were maintained in RPMI, supplemented with 5% fetal bovine serum, Lglutamine and antibiotics. MeWo neo , 196 ± 4, and 196 ± 9 clones were maintained in the same medium supplemented with G418 (200 mg/ml). WM3211 melanoma cells were maintained in MCDB153/L15 medium (4 : 1 ratio) supplemented with 5% FBS and insulin (5 mg/ml). In all cases, cells were grown at 378C with 5% CO 2 .
Protein preparation and immunological analysis
Nuclear proteins were isolated from each of the cells at the indicated time points after sham-treatment or u.v. exposure, using the method described by Dignam et al., (1983) . URE-bound proteins were puri®ed according to a method we developed (Rutberg and Ronai 1992) . Immunoprecipitation were performed using 1 mg of protein that was incubated with respective antibodies overnight at 48C. Agarose-bound protein A/G was used to precipitate antibody-bound proteins, which were then analysed on Western blot with respective antibodies using enhanced chemiluminescence (ECL, Amersham). In all cases ponceau to ensure equal amounts of proteins staining was performed on membranes after electroblotting.
Oligonucleotide synthesis
Oligonucleotides representing a heteroduplex of the URE (ACTATGACAACAGCTATGACAACAGT) target sequences (underlined) were synthesized using a Cyclone Plus DNA Synthesizer (Milligen Biosearch, Milford, MA) . Complementary DNA strands were puri®ed and annealed by standard procedures.
Similarly, oligonucleotides designed to amplify the 591 bp region of GAL4-ATF2 D1 ± 195 fusion protein were synthesized (upstream primers 5' TGA AAG ATG AAG CTA CTG 3' and reverse primer 5' AGG AAG ATGT AAC AGA AGAGG 3'). Endogenous ATF2 was used as a target for control ampli®cation with 5' ATF2 primer: 5' CA GAG GAA TCT CGA CCG 3' and the reverse primer 5' TCT CTA AAG ACT GAA CCC 3'.
Irradiation and chemical treatments
Cells were exposed to U.V. or X-radiation as previously described (Yang et al., 1996) . Drug resistance was evaluated for cis-platinum, mitomycin C and araC (Sigma) each of which was added in concentrations indicated under results, to 3 000 cells (per 6 well dishes). After 48 h cells were washed with PBS and fresh medium was added for 10 additional days.
Transfection and CAT assay
30 mg of the pURE-CAT (Rutberg et al., 1994) , or the parent pCAT-enhancer plasmids (Promega) were electroporated together with a bgal construct (10 mg) into 1610 7 cells. The degree of chloramphenicol conversion to the acetylated form was quantitated with a radioimaging blot analyser (AMBIS). Correction for transcriptional activity was based on values obtained for the pURE-CAT relative to the values obtained for the parent pCAT-enhancer vector. All values were adjusted as per b-Gal activities measured in the same protein preparations.
Transfection of ATF2 D1 ± 195 into MeWo cells and selection of clones
The pECE-ATF2 D1 ± 195 is a truncated ATF2 cDNA, lacking the ®rst 195 aa and cloned in frame to create a fusion protein with GAL4. This fusion protein consists of the ®rst 147 aa of GAL4, followed by 309 aa of ATF2 (aa 196 ± 505) , and this is under the regulation of SV40 early promoter (Liu and Green 1990) . MeWo cells (10 7 ) were cotransfected with the pECE-ATF2 D1 ± 195 construct (30 mg) and with pBK-RSV-neo gene (Stratagene) using electroporation (IBI GeneZapper) at 230V and 1050 mF in 25 mM HEPES, pH 7.1, 0.25 mM NaHPO 4 and 140 mM NaCl. In parallel, a pECE construct that lacks ATF2 cDNA was co-transfected with a pBK-RSV-neo construct to generate the control MeWo neo cells. After electroporation cells were plated at a density of 10 6 cells per 100 mm dish and were maintained in normal growth medium for 48 h. The medium was then supplemented with G418 (200 mg/ml) and cells were maintained for 14 days before colonies were isolated and analysed for the presence of the ATF2 D1 ± 195 in their genomic DNA. To this end, genomic DNA, prepared from the clones, was subjected to PCR ampli®cation using primers that correspond to GAL4 and ATF2, respectively. Only clones found to carry the transfected DNA were used for subsequent analysis.
Transient transfections were performed with DOTAP (Boehringer Mannheim) according to manufacturer's recommendations. pECE-ATF2 wt and pECE-ATF2 69,71thr ± ala mutant (Gupta et al., 1995) are full length ATF2 that lack the GAL4 fusion protein; pSLME6, is a mammalian expression vector with ERCC6 cDNA under the control of SV40 promoter.
Analysis of ATF2
D1 ± 195 expression in the selected clones mRNA prepared from MeWo, and from each of the selected clones, was reverse transcribed with the aid of oligo dT and AMV reverse transcriptase (Promega, Madison, OH); cDNAs were used as templates for PCR ampli®cation. Primers corresponding to GAL4 (5') and ATF2 (3') generated a 591 bp fragment. PCR was performed for 35 cycles (1' at 948C, 1' at 578C and 1' at 728C) using dNTP (0.2 mM), Taq (0.5 U; Promega), and Taq buer which contained 1.5 mM MgCl 2 . Parallel ampli®cation of endogenous ATF2 transcripts was carried out using 5' and 3' primers of ATF2 which¯ank the DNA binding domain generating a 219 bp fragment. Following ampli®cation, 20% of the product (10 ml) was analysed on 7.5% PAGE, stained with ethidium bromide.
Resistance to irradiation
The degree of radiation resistance was calculated by measuring the ability to grow independent clones after irradiation (at doses indicated in Results). The clones were counted 14 days after treatment. Under all circumstances, plating eciency was pre-determined and dierent numbers of cells were plated to normalize the number of cells at the initial phase of the experiment. Only clones consisting of more than 50 cells were counted.
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